Implanet S.A. (EPA:ALIMP)

Market Cap	30.27M
Revenue (ttm)	11.10M
Net Income (ttm)	-4.81M
Shares Out	125.60M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	174,008
Average Volume	238,467
Open	0.2410
Previous Close	0.2410
Day's Range	0.2380 - 0.2460
52-Week Range	0.0800 - 0.4445
Beta	0.78
RSI	39.49
Earnings Date	Oct 29, 2025

About Implanet

Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. Implanet S.A.was founded in 2006 and is based in Martill...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 46
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIMP

Financial Performance

In 2024, Implanet's revenue was 9.41 million, an increase of 26.31% compared to the previous year's 7.45 million. Losses were -4.37 million, -34.60% less than in 2023.